LASERS IN DENTAL TREATMENT WITHOUT NEEDLES AND DRILLS
Dr Omar Zuaiter
Co-Founder & Chief Executive Officer, Dentroid
Alaa Habeb
Co-Founder & Chief Technology Officer, Dentroid
Professor Laurence Walsh
Chief Dental Officer, Dentroid &
Emeritus Professor, School of Dentistry, University of Queensland &
Adjunct Professor, Griffith University, Queensland
Professor Heiko Spallek
Member Scientific Advisory Committee, Dentroid &
Head of School and Dean of The University of Sydney School of Dentistry
BENCH SIDE STORY CASE STUDY
Filmed in Brisbane, Canberra & Sydney | December 2024
In 2017, Dr. Omar Zuaiter and Alaa Habeb launched Dentroid, a dental technology startup with a mission to make dentistry a kinder and friendlier experience for patients and dentists using photonics (using laser technology) and robotics, as alternatives to needles, drills and sprays. The vision for the startup is to have dentistry adopt laser technology, addressing the root causes of dental pain & anxiety, and create a pain-free dental experience.
Dentroid is pioneering the adoption of femtosecond lasers in dentistry which will be their first surgical application outside eye surgery. Unlike conventional dental lasers or rotary instruments, femtosecond lasers have a very unique ability to precisely cut through the most resistant materials without requiring cooling or causing thermal damage. This “cold cutting” creates convenience for the patient, clearer vision for the practitioner and a cleaner environment in the office without microbes laden droplets.
A key distinctive feature of femtosecond laser in “cold cutting” is that it leaves the underlying tissues unharmed with the aim of supporting faster healing with less postoperative complications.
Dentroid envisages femtosecond lasers, combined with their patented miniaturised robotic technology will change the way dental tissues and restorative materials are prepared, processed and bonded not only in clinics but also in dental labs.
To support this mission, Dentroid has assembled a multidisciplinary team of world-renowned experts in dentistry and medicine, engineering, robotics, physics, medical sciences and AI informatics together with commercialisation and growth minds who helped scale startups grow to much larger organisations.
In this Bench Side Story Case Study release, we spoke with some of the key people involved in Dentroid mission and commercialisation journey.
FORWARD LOOKING STATEMENTS
This case study may contain projections and forward-looking statements that involve risks and uncertainties, including statements regarding the potential benefits and success of the drug or therapeutic. Actual results could differ materially from those anticipated in these forward-looking statements due to various factors, including but not limited to the risks and uncertainties associated with drug or device development and regulatory approval processes.
Viewers are advised content is for awareness and entertainment purposes only.
-
Care workforce challenges
In a wide ranging report looking at the carer needs across Australia, PwC Australia published Reimagine Care Workforce Solutions in October 2022.
Australian Health Journal spoke with Kerryn Dillon, Director Ageing and Reablement and Health Workforce at PwC Australia about the community care sectors of aged care, disability care and childcare the report covers.
-
The role of genomic screening in transforming public health
Dr Jane Tiller is a lawyer, genetic counsellor and public health researcher. She is Ethical, Legal & Social Adviser in Public Health Genomics at Monash University, and a National Health and Medical Research Council Investigator Grant holder. Jane is passionate about the use of genomics to prevent disease, and in delivering equitable access to preventive genetic information at the population level. She is co-lead of DNA Screen, a world-first study piloting the offer of preventive DNA screening to the Australian adult population. DNA Screen has tested over 10,000 young people for genetic high risk of medically actionable conditions such as cancer and heart disease, finding about 2% of participants had genetic high risk. Jane is leading efforts to secure Commonwealth Government funding to expand the DNA Screen program, with the eventual goal of the development of a public health population screening program for disease prevention based on high genetic risk.
-
Improving access to osteopathic services and integrated care models
The Chief Executive Officer of Osteopathy Australia, Antony Nicholas spoke with Australian Health Journal about:
– Involvement in the Strengthening Medicare Task Force
– The unique skills osteopaths have that can address the chronic disease burden
– Current workforce issues around osteopaths and if enough are coming through via student placements
– How uploading data to My Health Record by osteopaths could assist team-based care of patients
– How the value of osteopaths in Residential Aged Care Facilities (RACFs) could be better understood and better access for residents
– The recommendations around aged care access to allied health services, including osteopathy
– The recommendations around consumer access to osteopaths and GP referrals
– Other osteopathy recommendations in the upcoming Federal BudgetIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
